Vanderbilt-ingram Cancer Center

This study tests whether adding rigosertib to pembrolizumab can help people with advanced melanoma that no longer responds to standard immunotherapy. The trial enrolled 7 adults with unresectable or metastatic melanoma. Researchers are measuring how many patients' tumors shrink o…

This study looks at ways to help people who have genetic changes that increase cancer risk. The goal is to see if certain programs can help them follow medical guidelines for managing their cancer risk and share their genetic test results with family members. About 720 adults wit…

This study follows 45 uninsured current or former heavy smokers to find better ways to detect lung cancer early. Researchers will collect samples, perform CT scans, and review medical records over time. The goal is to validate biomarkers that could lead to earlier diagnosis in a …